Neumora Therapeutics, Inc. Insider Trading
NMRA
Insiders sold 784K and bought nothing on the open market.
1% of the selling was scheduled in advance under 10b5-1 plans. See Remarks Daljit Singh Aurora sold 432K on Aug 19, 79% of their stake, outside a plan. The last open-market buy by an executive or director was in Oct 2025.
Get an email when NMRA's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Aug 20 – 21 | Daljit Singh Aurora See Remarks | SoldNo plan 4 parts | 176,060 | $1.53 average | 269K | 78% | Form 4 |
| Aug 17 – 19 | Daljit Singh Aurora See Remarks | SoldNo plan 7 parts | 277,773 | $1.56 average | 432K | 79% | Form 4 |
| Feb 17 | Daljit Singh Aurora See Remarks | SoldNo plan | 6,165 | $3.56 | 22K | 6.9% | Form 4 |
| Feb 17 | Joshua Pinto President | SoldNo plan | 5,967 | $3.54 | 21K | 2.8% | Form 4 |
| Feb 17 | Paul L Berns See Remarks | SoldNo plan | 9,819 | $3.51 | 34K | 0.1% | Form 4 |
| Feb 17 | Michael Lee Milligan See Remarks | Sold10b5-1 plan | 1,436 | $3.57 | 5K | 6.4% | Form 4 |
| Nov 11, 2025 | Daljit Singh Aurora See Remarks | Sold10b5-1 plan | 114,703 | $2.68 | 307K | 56% | Form 4 |
| Oct 27, 2025 | Kristina Burow Director | Bought | 1,915,700 | $2.61 | $5M | 6.0% | Form 4 |
| Oct 27, 2025 | Arch Venture Partners Xii, LLC Large holder | Bought | 1,915,700 | $2.61 | $5M | 6.0% | Form 4 |
| Oct 27, 2025 | Arch Venture Partners Viii, LLC Large holder | Bought | 1,915,700 | $2.61 | $5M | 6.0% | Form 4 |
| Feb 18, 2025 | Paul L Berns See Remarks | Sold10b5-1 plan | 13,871 | $1.69 | 23K | 0.2% | Form 4 |
| Feb 18, 2025 | Michael Lee Milligan See Remarks | Sold10b5-1 plan | 1,978 | $1.69 | 3K | 8.1% | Form 4 |
| Feb 18, 2025 | Daljit Singh Aurora Chief Strategy Officer | Sold10b5-1 plan | 8,565 | $1.68 | 14K | 4.0% | Form 4 |
| Feb 18, 2025 | Robert A. Lenz Head of R&D | Sold10b5-1 plan | 5,614 | $1.67 | 9K | 1.8% | Form 4 |
| Feb 18, 2025 | Joshua Pinto President | Sold10b5-1 plan | 8,048 | $1.67 | 13K | 3.6% | Form 4 |
- Aug 20 – 21No planDaljit Singh AuroraSee Remarks · sold 176,060 at avg $1.53269K78% of stake
- Aug 17 – 19No planDaljit Singh AuroraSee Remarks · sold 277,773 at avg $1.56432K79% of stake
- Feb 17No planDaljit Singh AuroraSee Remarks · sold 6,165 at $3.5622K6.9% of stake
- Feb 17No planJoshua PintoPresident · sold 5,967 at $3.5421K2.8% of stake
- Feb 17No planPaul L BernsSee Remarks · sold 9,819 at $3.5134K0.1% of stake
- Feb 1710b5-1 planMichael Lee MilliganSee Remarks · sold 1,436 at $3.575K6.4% of stake
- Nov 11, 202510b5-1 planDaljit Singh AuroraSee Remarks · sold 114,703 at $2.68307K56% of stake
- Oct 27, 2025Kristina BurowDirector · bought 1,915,700 at $2.61$5M6.0% of stake
- Oct 27, 2025Arch Venture Partners Xii, LLCLarge holder · bought 1,915,700 at $2.61$5M6.0% of stake
- Oct 27, 2025Arch Venture Partners Viii, LLCLarge holder · bought 1,915,700 at $2.61$5M6.0% of stake
- Feb 18, 202510b5-1 planPaul L BernsSee Remarks · sold 13,871 at $1.6923K0.2% of stake
- Feb 18, 202510b5-1 planMichael Lee MilliganSee Remarks · sold 1,978 at $1.693K8.1% of stake
- Feb 18, 202510b5-1 planDaljit Singh AuroraChief Strategy Officer · sold 8,565 at $1.6814K4.0% of stake
- Feb 18, 202510b5-1 planRobert A. LenzHead of R&D · sold 5,614 at $1.679K1.8% of stake
- Feb 18, 202510b5-1 planJoshua PintoPresident · sold 8,048 at $1.6713K3.6% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Biological Products, (No Diagnostic Substances) · Pick stocks to compare with NMRA
Held by ETFs
NMRA is in 5 US ETFs. The largest of them, with NMRA's weight in each:
Spot a number that looks wrong? Check it in NMRA's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing NMRA
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.